Company ABL Diagnostics

Equities

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 15:30:08 29/04/2024 BST 5-day change 1st Jan Change
3.06 EUR 0.00% Intraday chart for ABL Diagnostics -3.77% -68.45%

Business Summary

ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases.

Export accounts for 69.3% of net sales.

Number of employees: 21

Managers

Managers TitleAgeSince
Chief Executive Officer - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Chairman - -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,114,656 57,880 ( 0.3592 %) 752 ( 0.004667 %) 0.3592 %

Shareholders

NameEquities%Valuation
Advanced Biological Laboratories SA
99.64 %
16,056,024 99.64 % 55 M €
La Mondiale SAM (Investment Portfolio)
0.001390 %
224 0.001390 % 769 €

Company contact information

ABL Diagnostics SA

42, rue Olivier Métra - Bat E1

75020, Paris

+33 3 87 17 81 56

http://www.fauvet-girel.fr
address ABL Diagnostics(ABLD)
  1. Stock Market
  2. Equities
  3. ABLD Stock
  4. Company ABL Diagnostics